102 related articles for article (PubMed ID: 11721410)
21. Heparin cofactor II: purification and antibody production.
Tran TH; Lämmle B; Zbinden B; Duckert F
Thromb Haemost; 1986 Feb; 55(1):19-23. PubMed ID: 3518132
[TBL] [Abstract][Full Text] [Related]
22. Uptake of heparin cofactor II and antithrombin into the aorta wall after a deendothelializing injury in vivo: comparison with the behaviors of prothrombin and fibrinogen.
Hatton MW; Ross B; Southward SM; Dereske M; Hoogendoorn H; Blajchman MA; Richardson M
J Lab Clin Med; 1999 Jan; 133(1):81-7. PubMed ID: 10385486
[TBL] [Abstract][Full Text] [Related]
23. Heparin cofactor II-thrombin complex in MPS I: a biomarker of MPS disease.
Randall DR; Sinclair GB; Colobong KE; Hetty E; Clarke LA
Mol Genet Metab; 2006 Jul; 88(3):235-43. PubMed ID: 16497528
[TBL] [Abstract][Full Text] [Related]
24. [Changes of T-helper 1 and T-helper 2 ratio in peripheral blood and decidua in hypertensive disorder complicating pregnancy].
Lü YP; Zhang WZ; Lu SY; Xin H
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):103-6. PubMed ID: 16640858
[TBL] [Abstract][Full Text] [Related]
25. Low plasma volume following pregnancy complicated by pre-eclampsia predisposes for hypertensive disease in a next pregnancy.
Aardenburg R; Spaanderman ME; Ekhart TH; van Eijndhoven HW; van der Heijden OW; Peeters LL
BJOG; 2003 Nov; 110(11):1001-6. PubMed ID: 14592585
[TBL] [Abstract][Full Text] [Related]
26. The selectins E and P in normal labour. A preliminary report on evaluation of their prognostic values for preeclampsia.
Uszyński W; Uszyński M; Zekanowska E
Adv Med Sci; 2007; 52():262-4. PubMed ID: 18217430
[TBL] [Abstract][Full Text] [Related]
27. Proteolytic activation transforms heparin cofactor II into a host defense molecule.
Kalle M; Papareddy P; Kasetty G; Tollefsen DM; Malmsten M; Mörgelin M; Schmidtchen A
J Immunol; 2013 Jun; 190(12):6303-10. PubMed ID: 23656734
[TBL] [Abstract][Full Text] [Related]
28. Plasma adiponectin concentrations and placental adiponectin expression in pre-eclamptic women.
Ichida K; Moriyama T; Morita H; Kondo T; Yoshida S; Ohara N; Maruo T
Gynecol Endocrinol; 2007 Apr; 23(4):238-43. PubMed ID: 17505945
[TBL] [Abstract][Full Text] [Related]
29. Plasma heparin cofactor II activity is inversely associated with left atrial volume and diastolic dysfunction in humans with cardiovascular risk factors.
Ise T; Aihara K; Sumitomo-Ueda Y; Yoshida S; Ikeda Y; Yagi S; Iwase T; Yamada H; Akaike M; Sata M; Matsumoto T
Hypertens Res; 2011 Feb; 34(2):225-31. PubMed ID: 21107326
[TBL] [Abstract][Full Text] [Related]
30. [Expression of fms-like tyrosine kinase receptor 1 in placenta of pre-eclampsia].
Hou XH; Li DH; Li Y; Zhao HX; Zhang CL; Huang L; Yao YQ
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):736-9. PubMed ID: 17327029
[TBL] [Abstract][Full Text] [Related]
31. Correlation between maternal plasma thrombomodulin and infant birth weight in hypertensive disorders of pregnancy.
Varol FG; Ozgen L; Sayin NC; Demir M
Clin Appl Thromb Hemost; 2009; 15(2):166-70. PubMed ID: 19022800
[TBL] [Abstract][Full Text] [Related]
32. Total peroxyl radical-trapping ability and anti-oxidant vitamins of the umbilical venous plasma and the placenta in pre-eclampsia.
Kim YH; Kim CH; Cho MK; Kim KM; Lee SY; Ahn BW; Yang SY; Kim SM; Song TB
J Obstet Gynaecol Res; 2006 Feb; 32(1):32-41. PubMed ID: 16445523
[TBL] [Abstract][Full Text] [Related]
33. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
[TBL] [Abstract][Full Text] [Related]
34. Endothelin-1 activity in pregnancy.
Khedun SM; Naicker T; Moodley J
J Obstet Gynaecol; 2002 Nov; 22(6):590-3. PubMed ID: 12554242
[TBL] [Abstract][Full Text] [Related]
35. Strain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient mice.
Aihara K; Azuma H; Akaike M; Ikeda Y; Sata M; Takamori N; Yagi S; Iwase T; Sumitomo Y; Kawano H; Yamada T; Fukuda T; Matsumoto T; Sekine K; Sato T; Nakamichi Y; Yamamoto Y; Yoshimura K; Watanabe T; Nakamura T; Oomizu A; Tsukada M; Hayashi H; Sudo T; Kato S; Matsumoto T
J Clin Invest; 2007 Jun; 117(6):1514-26. PubMed ID: 17549254
[TBL] [Abstract][Full Text] [Related]
36. An enzyme-linked immunosorbent assay for heparin cofactor II (HCII). Application to the measurement of HCII in clinical materials.
Toulon P; Costa JM; Amiral J
Clin Chim Acta; 1992 Jan; 205(1-2):65-73. PubMed ID: 1521342
[TBL] [Abstract][Full Text] [Related]
37. The effect of labour and placental separation on the shedding of syncytiotrophoblast microparticles, cell-free DNA and mRNA in normal pregnancy and pre-eclampsia.
Reddy A; Zhong XY; Rusterholz C; Hahn S; Holzgreve W; Redman CW; Sargent IL
Placenta; 2008 Nov; 29(11):942-9. PubMed ID: 18834630
[TBL] [Abstract][Full Text] [Related]
38. Significance of high levels of heparin cofactor II in the plasma and urine of adult patients with nephrotic syndrome.
Toulon P; Gandrille S; Remy P; Chadeuf G; Jouvin MH; Aiach M
Nephron; 1992; 60(2):176-80. PubMed ID: 1553002
[TBL] [Abstract][Full Text] [Related]
39. Low plasma heparin cofactor II levels in thalassaemia syndromes are corrected by chronic blood transfusion.
O'Driscoll A; Mackie IJ; Porter JB; Machin SJ
Br J Haematol; 1995 May; 90(1):65-70. PubMed ID: 7786797
[TBL] [Abstract][Full Text] [Related]
40. Altering heparin cofactor II at VAL439 (P6) either impairs inhibition of thrombin or confers elastase resistance.
Cunningham MA; Bhakta V; Sheffield WP
Thromb Haemost; 2002 Jul; 88(1):89-97. PubMed ID: 12152684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
